AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON") and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics ("Cyncado") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback